Latest papers

Skin graft take rates, granulation, and epithelialization: dependence on myeloid cell hypoxia-inducible factor 1alpha.

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

Cancer-associated myeloproliferation: old association, new therapeutic target.

Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.

Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.